We are live on ! Find out more
FIG

Freed Investment Group Portfolio holdings

AUM $131M
1-Year Est. Return 30.59%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+30.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$5.68M
Cap. Flow
+$2.32M
Cap. Flow %
2.02%
Top 10 Hldgs %
98.93%
Holding
17
New
1
Increased
5
Reduced
6
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Communication Services 7.03%
3 Consumer Discretionary 5.79%
4 Financials 4.62%
5 Healthcare 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONEQ icon
1
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
$39.5M 34.51%
770,040
-38,440
-5% -$1.99M
IVV icon
2
iShares Core S&P 500 ETF
IVV
$881B
$35.1M 30.62%
88,210
+3,157
+4% +$1.22M
AAPL icon
3
Apple
AAPL
$4.9T
$6.68M 5.83%
54,695
-556
-1% -$71.4K
AMZN icon
4
Amazon
AMZN
$2.66T
$6.63M 5.79%
42,880
-720
-2% -$114K
DIA icon
5
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
$5.9M 5.15%
17,876
+10,192
+133% +$3.22M
MSFT icon
6
Microsoft
MSFT
$2.93T
$5.61M 4.89%
23,775
+971
+4% +$225K
V icon
7
Visa
V
$682B
$5.3M 4.62%
25,018
+1,246
+5% +$262K
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.22T
$4.14M 3.61%
40,000
+4,200
+12% +$417K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.23T
$3.92M 3.42%
38,020
-1,660
-4% -$164K
JNJ icon
10
Johnson & Johnson
JNJ
$609B
$548K 0.48%
3,336
-310
-9% -$50.2K
NVDA icon
11
NVIDIA
NVDA
$4.91T
$400K 0.35%
29,960
CDAK
12
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$307K 0.27%
20,328
VIR icon
13
Vir Biotechnology
VIR
$1.59B
$256K 0.22%
+5,000
New +$269K
SPY icon
14
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$242K 0.21%
610
CTXR icon
15
Citius Pharmaceuticals
CTXR
$13.6M
$26K 0.02%
584
-556
-49% -$22.1K
GDX icon
16
VanEck Gold Miners ETF
GDX
$21.8B
-15,600
Closed -$562K
META icon
17
Meta Platforms (Facebook)
META
$1.64T
-1,179
Closed -$322K

Similar funds

Freed Investment Group's Q1 2021 Portfolio in Review

As of Q1 2021, Freed Investment Group held 17 positions worth $115M, up 5.2% from $109M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Freed Investment Group's Q1 2021 filing shows 1 new, 5 increased, 6 reduced and 2 closed positions. Its largest new stake was Vir Biotechnology: 5,000 shares worth $256K. The largest sale was Fidelity Nasdaq Composite Index ETF, an estimated $1.99M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Freed Investment Group's largest Q1 2021 buy was Vir Biotechnology: 5,000 shares worth $256K.
  • Freed Investment Group added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2021, an estimated $3.22M increase.
  • Freed Investment Group's biggest Q1 2021 reduction was Fidelity Nasdaq Composite Index ETF, cutting an estimated $1.99M.
  • Freed Investment Group fully exited VanEck Gold Miners ETF in Q1 2021, selling an estimated $562K.
  • Freed Investment Group's ten largest holdings make up 99% of its $115M portfolio in Q1 2021.
  • Freed Investment Group opened 1 new position and closed 2 in Q1 2021.
  • Freed Investment Group's portfolio value rose 5.2% quarter-over-quarter to $115M.

Based on Freed Investment Group's 13F filing for Q1 2021, filed 26 Apr 2021.